Business registries · firm from USPTO records
Dana-Farber Cancer Institute, Inc.
- Place
- 450 Brookline Avenue, Boston, MA
- Entity type
- Entity code 54
- State of organization
- MA (as the owner states it in trademark filings)
- Patents
- 824 granted 1988-06-29 to 2025-12-30
- Trademarks
- 44, 37 live
- Record
- EXACT high confidence: identical full name and state
- Federal lobbying client
- DANA-FARBER CANCER INSTITUTE, INC. EXACT high confidence: identical full name and state
- Nonprofit
- DANA-FARBER CANCER INSTITUTE FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12760370 | Methods of producing human cancer cell models and methods of use | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12760035 | Covalent EGFR inhibitors and methods of use thereof | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12758631 | Personalized fusion cell vaccines | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12753208 | Antiviral structurally-stabilized Ebolavirus peptides and uses thereof | 2026-10-06 | PTBLXML, file of 2026-10-06 |
| US 12753203 | Cyclin-dependent kinase inhibitors and methods of use | 2026-10-06 | PTBLXML, file of 2026-10-06 |
| US 12747228 | Potent and selective inhibitors of IRAK4 | 2026-09-29 | PTBLXML, file of 2026-09-29 |
| US 12735463 | Peptide tags for ligand induced degradation of fusion proteins | 2026-09-15 | PTBLXML, file of 2026-09-15 |
| US 12729225 | Non-canonical SWI/SNF complex and uses thereof | 2026-09-08 | PTBLXML, file of 2026-09-08 |
| US 12729194 | Compounds for the treatment of human immunodeficiency virus | 2026-09-08 | PTBLXML, file of 2026-09-08 |
| US 12728132 | Inhibitors of the peptidyl-prolyl cis/trans isomerase (PIN1), combinations and uses thereof | 2026-09-08 | PTBLXML, file of 2026-09-08 |
| US 12714691 | Method of treating triple-negative breast cancer | 2026-08-25 | PTBLXML, file of 2026-08-25 |
| US 12709607 | Potent and selective irreversible inhibitors of IRAK1 | 2026-08-18 | PTBLXML, file of 2026-08-18 |
| US 12702694 | Methods for identification, assessment, prevention, and treatment of metabolic disorders using SLIT2 | 2026-08-11 | PTBLXML, file of 2026-08-11 |
| US 12698261 | Cyano-pyrimidine inhibitors of EGFR/HER2 | 2026-08-04 | PTBLXML, file of 2026-08-04 |
| US 12698259 | Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof | 2026-08-04 | PTBLXML, file of 2026-08-04 |
| US 12697313 | Methods of treating anemia using formoterol or a pharmaceutically acceptable salt thereof | 2026-08-04 | PTBLXML, file of 2026-08-04 |
| US 12692261 | Substituted heterocyclic compounds and therapeutic uses thereof | 2026-07-28 | PTBLXML, file of 2026-07-28 |
| US 12692250 | USP7 inhibitors for treating multiple myeloma | 2026-07-28 | PTBLXML, file of 2026-07-28 |
| US 12685776 | Arginine methyltransferase 5 (PRMT5) degraders and uses thereof | 2026-07-21 | PTBLXML, file of 2026-07-21 |
| US 12679842 | HCK as a therapeutic target in MYD88 mutated diseases | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12679836 | 4H-pyrrolo[3,2-c]pyridin-4-one compounds | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12678508 | Compounds for targeted degradation of interleukin-2-inducible T-cell kinase and methods of use | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12668571 | Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28 | 2026-06-30 | PTBLXML, file of 2026-06-30 |
| US 12662540 | Compositions and methods for inhibition of MICA/B shedding | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12662464 | Degraders of cyclin-dependent kinase 12 (CDK12) and uses thereof | 2026-06-23 | PTBLXML, file of 2026-06-23 |
The newest 25 of 824. All patents of this assignee
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| MARLIN | 50059132 | 2026-08-19 | Pending application | 009, 042 | TRTDXFAP, file of 2026-08-20 |
| DEFY CANCER | 99418761 | 2025-09-29 | Pending application | 036 | TRTDXFAP, file of 2026-10-17 |
| TRANSTAC | 98225361 | 2023-10-16 | Pending application | 001, 005 | TRTDXFAP, file of 2026-05-21 |
| 29F.1A12 | 97914761 | 2023-05-01 | Registered | 001, 005 | TRTYRAP, file of 2026-04-03 |
| 29E.2A3 | 97914757 | 2023-05-01 | Registered | 001, 005 | TRTYRAP, file of 2026-04-03 |
| 10F.9G2 | 97914749 | 2023-05-01 | Registered | 001, 005 | TRTYRAP, file of 2026-04-03 |
| BINNEY STREET CAPITAL | 88914528 | 2020-05-13 | Registered | 036 | TRCFECO2, file of 2024-03-27 |
| EMBRACE | 88886223 | 2020-04-24 | Registered | 042 | TRCFECO2, file of 2024-03-27 |
| JIMMY FUND LET'S GAME | 88772058 | 2020-01-24 | Registered | 036 | TRTDXFAP, file of 2026-01-28 |
| THE JIMMY FUND | 88636054 | 2019-09-30 | Registered | 036 | TRTDXFAP, file of 2026-05-08 |
| JIMMY FUND | 88634376 | 2019-09-27 | Registered | 036 | TRTDXFAP, file of 2026-05-08 |
| (design) | 88634306 | 2019-09-27 | Registered | 036 | TRTDXFAP, file of 2026-05-08 |
| DANA-FARBER CANCER INSTITUTE | 88553477 | 2019-07-31 | Registered | 042, 044 | TRTYRAP, file of 2026-04-03 |
| WHAT WE DO HERE, CHANGES LIVES EVERYWHERE | 88550509 | 2019-07-30 | Registered | 042, 044 | TRTDXFAP, file of 2026-09-11 |
| DF | 88550432 | 2019-07-30 | Registered | 042, 044 | TRTDXFAP, file of 2026-05-08 |
| DF DANA-FARBER CANCER INSTITUTE | 88550326 | 2019-07-30 | Registered | 042, 044 | TRTDXFAP, file of 2026-05-08 |
| DANA-FARBER CANCER SENSE | 87903507 | 2018-05-02 | Abandoned | 042, 044 | TRCFECO2, file of 2024-03-27 |
| CANCER SENSE | 87903407 | 2018-05-02 | Abandoned | 042, 044 | TRCFECO2, file of 2024-03-27 |
| ALL SYNDROMES KNOWN TO MAN EVALUATOR | 87896266 | 2018-04-27 | Registered | 038, 042, 044 | TRTDXFAP, file of 2026-05-18 |
| ASK2ME | 87896180 | 2018-04-27 | Registered | 038, 042, 044 | TRTDXFAP, file of 2026-05-18 |
| ALL TOGETHER, DIFFERENT | 87880404 | 2018-04-17 | Abandoned | 042, 044 | TRCFECO2, file of 2024-03-27 |
| (design) | 87518281 | 2017-07-06 | Registered | 036, 041 | TRTYRAP, file of 2026-04-03 |
| SCOOPER BOWL | 87518239 | 2017-07-06 | Registered | 036, 041 | TRTYRAP, file of 2026-04-03 |
| PREMM | 87406871 | 2017-04-11 | Registered | 044 | TRCFECO2, file of 2024-03-27 |
| DISCOVER. CARE. BELIEVE. | 86590814 | 2015-04-08 | Registration cancelled | 042, 044 | TRCFECO2, file of 2024-03-27 |
The newest 25 of 44. All marks of this owner
Possible related entities
- Upstate Group, Inc. firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.